TRIM33 and clinically amyopathic dermatomyositis: Anti-TIF1-gamma autoantibody results from the LB assay for detecting CADM had a sensitivity of 40% and specificity of 96%, which was a significantly lower sensitivity compared with ELISAs and IP (P < 0.05).